Showing 41 results

Archival description
UoA 8
Print preview
Card view Table view
Show 35 results with digital objects
[F] Evaluation of BioMin toothpaste
[F] Evaluation of BioMin toothpaste
[F] Low carbon and renewable energy economy, UK: 2018
[F] Low carbon and renewable energy economy, UK: 2018
[F] New cancer drug class unveiled at Imperial
[F] New cancer drug class unveiled at Imperial
[F] SweetGen: abiotic wastewater fuel cell
[F] SweetGen: abiotic wastewater fuel cell
[G] Amazon sales page of BioMin toothpaste
[G] Amazon sales page of BioMin toothpaste
[G] Better Future. A Route Map to Creating a Cleantech Cluster in London.
[G] Better Future. A Route Map to Creating a Cleantech Cluster in London.
[G] CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML
[G] CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML
Green chemistry research and innovation policy driving a world-class cleantech cluster in London
Green chemistry research and innovation policy driving a world-class cleantech cluster in London
[H] ECONIC NAMED 2019 GLOBAL CLEANTECH 100 COMPANY
[H] ECONIC NAMED 2019 GLOBAL CLEANTECH 100 COMPANY
[H] ECONIC WINS SHELL UK CHAIRMAN SPECIAL AWARD AT SHELL SPRINGBOARD 2015!
[H] ECONIC WINS SHELL UK CHAIRMAN SPECIAL AWARD AT SHELL SPRINGBOARD 2015!
[H] Mayor of London, About Better Futures
[H] Mayor of London, About Better Futures
[H] New drug class unveiled at Imperial
[H] New drug class unveiled at Imperial
[I] BioMin receives FDA Approval
[I] BioMin receives FDA Approval
[I] Evotec Partnered Drug Discovery and Development
[I] Evotec Partnered Drug Discovery and Development
[I] Letter from Secretary of State approving the London Plan
[I] Letter from Secretary of State approving the London Plan
[I] Press coverage of Econic
[I] Press coverage of Econic
[I] The London Plan. Mayor of London.
[I] The London Plan. Mayor of London.
Interdisciplinary Chemistry-led research leading to new ventures in Drug Discovery, Diagnostics and Personal Care
Interdisciplinary Chemistry-led research leading to new ventures in Drug Discovery, Diagnostics and Personal Care
[K] CleanTech London.
[K] CleanTech London.
The Invention of Samuraciclib, a Highly Selective CDK-7 Inhibitor, the Formation of Carrick Therapeutics and Clinical Trials on Treating Patients with Resistant Cancers
The Invention of Samuraciclib, a Highly Selective CDK-7 Inhibitor, the Formation of Carrick Therapeutics and Clinical Trials on Treating Patients with Resistant Cancers